Arrowhead Pharmaceuticals Balance Sheet (2010-2025) | ARWR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	372.38M	326.00M	184.43M		86.40M	139.40M	108.00M	202.25M	134.96M	105.33M	110.89M	58.22M	127.70M	69.40M	102.69M	53.89M	185.71M	129.80M	226.55M	201.64M
Short-term Investments (Quarter)	125.79M	63.92M	56.63M	126.01M	192.90M	277.10M	268.39M	299.60M	346.00M	346.37M	292.74M	162.10M	395.41M	367.30M	578.28M	499.05M	911.70M	770.58M	692.82M	714.97M
Cash & Current Investments (Quarter)	498.17M	389.92M	241.06M	126.01M	279.30M	416.50M	376.40M	501.85M	480.96M	451.70M	403.63M	220.31M	523.11M	436.70M	680.96M	552.93M	1,097.41M	900.38M	919.37M	916.61M
Receivables - Net (Quarter)	0.95M	0.67M	10.26M	0.15M	1.32M	0.24M	1.41M	39.57M	70.00M	1.54M						2.50M	2.37M	9.70M	6.82M	218.35M
Receivables - Other (Quarter)	0.60M	0.30M	10.00M	0.10M			4.80M	25.00M												9.83M
Receivables (Quarter)	1.55M	0.97M	20.25M	0.25M	1.32M	0.24M	6.21M	64.57M	70.00M	1.54M						2.50M	2.37M	9.70M	6.82M	228.18M
Prepaid Assets (Quarter)	1.84M	7.28M	2.19M	2.79M	6.62M	6.76M	20.20M	8.41M	14.44M	7.16M	4.03M	7.10M	11.02M	9.21M	9.54M	5.74M	23.77M	23.69M	10.93M	16.05M
Current Assets (Quarter)	586.76M	525.96M	384.60M	338.28M	417.63M	432.39M	405.30M	575.00M	574.81M	470.17M	416.47M	237.90M	541.65M	450.06M	695.47M	570.54M	1,135.22M	946.92M	950.64M	1,174.39M
Non-Current Assets
Construction in Progress (Quarter)			0.34M	2.15M	6.41M	22.34M	56.37M	90.22M	127.22M	118.28M	166.66M
Land & Improvements (Quarter)				3.00M	3.00M
Property, Plant & Equipment (Net) (Quarter)	39.40M	47.79M	48.67M	52.30M	54.89M	71.90M	110.30M	147.31M	185.23M	231.37M	290.26M	333.41M	359.25M	375.91M	386.03M	387.07M	384.80M	381.05M	382.51M	378.58M
Long-Term Investments (Quarter)	97.50M	128.38M	245.59M	217.60M	201.60M	165.92M	105.87M	115.80M	78.80M	42.80M
Intangibles (Quarter)	14.51M	14.09M	13.66M	13.24M	12.81M	12.39M	11.96M	11.54M	11.11M	10.69M	10.26M	9.84M	9.41M	8.99M	8.56M	8.14M	7.71M	7.29M	6.86M	6.44M
Goodwill & Intangibles (Quarter)	14.51M	14.09M	13.66M	13.24M	12.81M	12.39M	11.96M	11.54M	11.11M	10.69M	10.26M	9.84M	9.41M	8.99M	8.56M	8.14M	7.71M	7.29M	6.86M	6.44M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.27M	0.27M	0.27M	0.27M	0.28M	0.28M	0.22M	0.21M	0.21M	0.21M	3.26M	0.23M	0.21M	4.46M	4.48M	3.08M	1.31M	1.35M	1.39M	1.41M
Non-Current Assets (Quarter)	170.04M	208.97M	325.55M	300.26M	285.94M	319.39M	286.64M	316.49M	316.50M	325.69M	349.08M	388.39M	413.50M	433.70M	444.33M	443.16M	438.28M	433.69M	434.66M	429.79M
Assets (Quarter)	756.79M	734.93M	710.15M	638.54M	703.58M	751.78M	691.94M	891.49M	891.31M	795.86M	765.55M	626.29M	955.15M	883.76M	1,139.80M	1,013.69M	1,573.50M	1,380.61M	1,385.30M	1,604.18M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.30M	10.04M	9.46M	4.07M	10.60M	5.89M	2.87M	0.80M	9.56M	7.87M	35.87M	4.46M	8.52M	26.55M	11.39M	14.46M	9.98M	33.05M	17.67M	32.94M
Notes Payables (Quarter)
Payables (Quarter)	5.30M	10.04M	9.46M	4.07M	10.60M	5.89M	2.87M	0.80M	9.56M	7.87M	35.87M	4.46M	8.52M	26.55M	11.39M	14.46M	9.98M	33.05M	17.67M	32.94M
Accumulated Expenses (Quarter)	12.86M	3.65M	9.77M	2.97M	23.71M	32.50M	46.86M	48.17M	5.49M	38.19M	17.96M	8.78M	13.74M	47.90M	21.99M	11.28M	78.45M	19.30M	90.42M	14.27M
Other Accumulated Expenses (Quarter)	0.02M										0.43M	0.46M	0.57M	0.42M	0.43M	0.44M	0.45M	7.38M	10.81M	10.68M
Short term Debt (Quarter)																1.62M	65.00M	40.00M	40.00M	40.00M
Current Leases (Quarter)	1.27M	1.29M	2.25M	2.83M	2.91M	2.88M	2.78M	2.66M	2.71M	2.82M	10.56M	3.42M	5.29M	6.05M	6.34M	6.56M	6.78M	7.01M	7.29M	7.53M
Current Deferred Revenue (Quarter)	144.88M	150.93M	111.06M	108.65M	97.87M	84.29M	74.10M	66.28M	29.84M	16.91M	0.87M						43.27M	22.98M	2.40M	111.93M
Total Current Liabilities (Quarter)	167.19M	195.43M	146.54M	137.03M	138.86M	128.21M	138.85M	122.01M	87.15M	70.23M	105.46M	63.72M	65.17M	96.71M	103.17M	93.76M	220.54M	194.53M	195.49M	347.43M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)															393.18M	407.79M	208.93M	200.33M	214.88M	163.11M
Non-Current Deffered Revenue (Quarter)	121.53M	79.75M	131.50M	106.46M	89.75M	71.16M	55.95M	40.79M	1.07M											53.83M
Minority Interest (Quarter)						20.25M	19.82M	19.33M	18.33M	17.16M	15.82M	13.31M	11.61M	8.43M	5.62M	3.49M	0.90M	-2.51M	37.36M	-5.72M
Operating Leases (Quarter)	22.53M	22.85M	23.30M	22.49M	22.70M	78.23M	78.80M	82.13M	82.78M	82.73M	104.61M	115.16M	113.63M	112.04M	111.03M	109.30M	114.31M	105.69M	104.11M	109.66M
Other Non-Current Liabilities (Quarter)								252.85M	257.91M	263.06M	268.33M	273.69M	280.94M	336.03M	341.36M	346.78M	352.28M	360.25M	367.40M	375.00M
Total Non-Current Liabilities (Quarter)	144.06M	102.60M	154.79M	128.95M	112.45M	149.39M	134.75M	373.11M	339.05M	343.64M	372.93M	388.85M	394.57M	448.07M	845.57M	863.86M	668.73M	666.28M	686.39M	694.06M
Total Liabilities (Quarter)	311.25M	298.04M	301.33M	265.98M	251.31M	277.61M	273.60M	495.12M	426.20M	413.87M	478.39M	452.57M	459.75M	544.78M	948.74M	957.62M	889.27M	858.30M	881.88M	1,035.76M
Shareholder's Equity
Total Debt (Quarter)															393.18M	409.41M	273.93M	240.33M	254.88M	203.11M
Common Equity (Quarter)	445.55M	436.89M	408.82M	372.56M	452.27M	474.18M	418.34M	396.37M	465.11M	381.99M	287.16M	173.71M	495.40M	338.97M	191.06M	56.08M	684.23M	522.31M	503.42M	568.42M
Shareholder's Equity (Quarter)	445.55M	436.89M	408.82M	372.56M	452.27M	474.18M	418.34M	396.37M	465.11M	381.99M	287.16M	173.71M	495.40M	338.97M	191.06M	56.08M	684.23M	522.31M	503.42M	568.42M
Liabilities and Shareholders Equity (Quarter)	756.79M	734.93M	710.15M	638.54M	703.58M	751.78M	691.94M	891.49M	891.31M	795.86M	765.55M	626.29M	955.15M	883.76M	1,139.80M	1,013.69M	1,573.50M	1,380.61M	1,385.30M	1,604.18M
Treasury Shares (Quarter)	3.85M	3.85M	3.83M	3.58M	4.47M	4.47M	4.07M	2.31M	4.33M	1.89M	4.24M	0.68M	2.84M	5.03M		2.94M	0.49M
Retained Earnings (Quarter)	-551.39M	0.06M	-644.69M	-707.56M	-0.11M	-735.24M	-0.14M	-862.08M	-813.40M	-916.35M	-1026.03M	-1158.89M	-1.09M	-1454.99M	4.75M	4.14M	-1428.16M	-1603.40M	-1627.15M	-1596.34M
Preferred Shares (Quarter)

Research Tools

Arrowhead Pharmaceuticals Balance Sheet (2010-2025) | ARWR

Create an account

Sign In

Reset Password